Policy & regulation

The Queensland parliament has passed a new law restricting use of the title ‘surgeon’ to doctors registered in one of...

Australian optometrists and ophthalmologists will face an increase in their registration fees for 2023/24, with eye doctors facing a $135...

The US Food and Drug Administration (FDA) issued warning letters to eight firms marketing unapproved ophthalmic drug products. These warnings...

The outbreak of a lethal drug-resistant bacteria strain linked to an alleged eye drop manufacturing breakdown is one of the...

The US FDA has approved the use of high dose Eylea (aflibercept) for three macular conditions, equating to longer intravitreal...

A new report commissioned by the private health insurance (PHI) industry states medical devices used in surgery in Australia cost...

The trust and confidence that Australian eyecare professionals have in their regulator have taken a hit, according to a survey...

The US Food and Drug Administration (FDA) has approved a second therapy for geographic atrophy (GA), with IZERVAY (avacincaptad pegol...

Greater scrutiny of sexual misconduct in the healthcare system has led to sustained jump in reports to authorities as well...

The global health sector will continue to lose out unless measures are taken to accelerate towards equal representation of women...